Search for: "AMGEN INC." Results 561 - 580 of 704
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 May 2007, 2:39 am
High Court Turns Down Amgen's Appeal in Patent Case The Associated Press The Supreme Court on Monday declined to consider a patent dispute between biotech drug maker Amgen Inc. and two other companies involving Amgen's blockbuster anemia drug Epogen. [read post]
22 Aug 2012, 3:26 pm by David Jensen
Among other things, Weissman worked the exclusive Bohemian Grove in Northern California and “pitched” Bill Bowes, a co-founder of Amgen, who, along with his wife, gave $1.3 million to the campaign. [read post]
31 Oct 2012, 11:00 pm by Paul Karlsgodt
Amgen, Inc., 660 F.3d 1170 (9th Cir. 2011) - Amgen raises the question whether the plaintiff must establish the materiality of an alleged false statement at the class certification stage of a securities fraud class action. [read post]
12 May 2015, 2:04 pm by James Galvin
The following is a list of some of the Barclays Reverse Convertible Notes offered: CUSIP Issuer Product Name 06740JJL5 Barclays Reverse Convertible Notes linked to Wells Fargo & Co. 06740JTD2 Barclays Reverse Convertible Notes linked to Wells Fargo & Co. 06740PGR1 Barclays Reverse Convertible Notes linked to Wells Fargo & Co. 06741JZQ5 Barclays Reverse Convertible Notes linked to 3D Systems Corp 06741J5M7 Barclays Reverse Convertible Notes linked to 3D Systems Corp 06741J3Y3 Barclays… [read post]
8 Oct 2009, 6:05 am
Teva Pharmaceuticals USA, Inc (Patent Docs) (Patent Baristas) (GenericsWeb)   General Biotech legislative agenda: healthcare, energy, patents and capital (IP Watch) India: Applying for patents does pay: Wockhardt wins kudos from the Indian government (SPICY IP) US: CAFC ruling in Board of Trustees of the Leland Stanford Junior University et al v Roche Molecular Systems et al - How to lose a patent? [read post]
31 Aug 2010, 10:01 pm by Kelly
Apotex Inc. et al (Docket Report) Lovenox (Enoxaparin) – US: DC District Court denies preliminary injunction in generic Lovenox case; Is the juice worth the squeeze for Sanofi to appeal? [read post]
14 Jun 2017, 4:18 am by Edith Roberts
” In another Monday ruling, the court held in Amgen Inc. v. [read post]
17 Oct 2008, 1:32 pm
Proposed EU information laws on prescription drugs (IPmed) Iceland: Supplementary Protection Certificates (SPCs) in Iceland (The SPC blog) India: Roche implements 'mass serialisation' anti-counterfeiting technology (Spicy IP) Indonesia: Patent application on oil palm hybrids (navigating the patent maze) United States: New PMCA research: State legislative proposals restricting access to generic medicines would increase cost $29 billion over 10 years (GenericsWeb) US: Pharmaceutical… [read post]
2 Dec 2011, 2:00 pm by Kiera Flynn
Susan HutchesonDocket: 11-269Issue(s): (1) Whether an allegation that a defendant has committed a statutory violation renders a claim submitted by an unrelated party “legally false” for purposes of the FCA, where no statute or regulation expressly conditions payment of the unrelated party’s claim on the defendant’s compliance; and (2) whether and when a private citizen is authorized to use a “legally false” theory under the False Claims Act as a generalized… [read post]
23 Oct 2008, 10:31 am
" Specifically, "infections triggered safety alerts for the arthritis medicines Enbrel (etanercept), sold by Amgen Inc.; Johnson & Johnson's Remicade (infliximab); and Abbott Laboratories' Humira (adalimumab). [read post]